Clinical Trial

Immune Status and Disease Control of Inflammatory Airway Diseases

Study acronym: ISDC-IAD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to learn how the body's immune system affects disease control in people with different airway inflammatory diseases.We want to understand: 1.Whether specific immune cell patterns in the blood are linked to how severe the disease is or how well it is controlled. Participants will: 1. Answer questions about their health and symptoms. 2. Give blood samples 3. Have lung function tests and other standard check-ups. 4. share sleep study results. We will compare people with airway diseases to healthy volunteers to see how their immune systems differ.
Trial Details
NCT Number NCT07493629
Lead Sponsor First Affiliated Hospital of Ningbo University
Conditions Airway Inflammation, Chronic Obstructive Pulmonary Disease (COPD), Asthma (Diagnosis), Bronchiectasis, OSAS (Obstructive Sleep Apneas Syndrome), Allergic Bronchopulmonary Aspergillosis (ABPA)
Enrollment 200 participants
Start Date 2025-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-25